l-Asparaginase Encapsulation into Asymmetric Permeable Polymersomes

Area of Science:

• Biotechnology
• Nanomedicine
• Enzyme Engineering

Background:

• L-asparaginase is a crucial anticancer enzyme.
• Efficient encapsulation of enzymes into nanocarriers is vital for therapeutic efficacy.
• Asymmetric polymersomes offer unique properties for drug delivery.

Purpose of the Study:

• To encapsulate L-asparaginase into PMPC25-PDPA70/PEO16-PBO22 asymmetric polymersomes.
• To evaluate the loading capacity and enzyme activity of the encapsulated L-asparaginase.
• To explore the potential of these nanoreactors for cancer therapy.

Main Methods:

• Encapsulation of L-asparaginase into pre-formed asymmetric polymersomes.
• Characterization of enzyme-loaded polymersomes.
• Assay of L-asparaginase activity and L-asparagine hydrolysis.

Main Results:

• High loading capacity exceeding 800 molecules per vesicle achieved.
• Encapsulated L-asparaginase demonstrated permeability and retained hydrolytic activity.
• Polymersomes maintained enzyme integrity and function.

Conclusions:

• Asymmetric polymersomes are effective nanocarriers for L-asparaginase.
• The developed nanoreactors show promise for cancer treatment strategies.
• Further research into L-asparaginase-based nanotherapeutics is warranted.